Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

NSP 805 MeSH Supplementary Concept Data 2025


MeSH Supplementary
NSP 805
Unique ID
C082248
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C082248
Entry Term(s)
4,5-dihydro-5-methyl-6-(4-((2-methyl-3-oxo-1-cyclopentenyl)amino)phenyl)-3-(2H)-pyridazinone
NSP-805
Registry Numbers
125068-54-4
CAS Type 1 Name
3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-(4-((2-methyl-3-oxo-1-cyclopenten-1-yl)amino)phenyl)-
Heading Mapped to
*Pyridazines
Frequency
2
Note
may have beneficial effects for treatment of congestive heart failure; structure given in first source
Source
J Cardiovasc Pharmacol 1993 Jun;21(6):983-95
Date of Entry
1993/08/18
Revision Date
2001/05/08
NSP 805 Preferred
4,5-dihydro-5-methyl-6-(4-((2-methyl-3-oxo-1-cyclopentenyl)amino)phenyl)-3-(2H)-pyridazinone Broader
page delivered in 0.004s